Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven van den Bosch

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Seminars in Radiation Oncology|June 18, 2023
[18F]FDG-PET-Based Personalized Radiotherapy Dose PrescriptionJohannes H A M Kaanders, Johan Bussink, Erik H J G Aarntzen, et al.
Head & Neck|March 7, 2017
Reirradiation of head and neck cancer: Long-term disease control and toxicityWouter T C Bots, Sven van den Bosch, Ellen M Zwijnenburg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 15, 2025
Clinical Benefit and Safety of Reduced Elective Dose in Definitive Radiotherapy for Head and Neck Squamous Cell Carcinoma: The UPGRADE-RT Multicenter Randomized Controlled TrialSven van den Bosch, Patricia A H Doornaert, Frank J P Hoebers, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 7, 2025
Dose de-escalation of elective neck irradiation in head and neck cancer: A secondary analysis of acute toxicity findings from the randomized controlled UPGRADE-RT trialSven van den Bosch, Maurice C Cox, Patricia A H Doornaert, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 24, 2019
<sup>18</sup>F-FDG-PET/CT-based treatment planning for definitive (chemo)radiotherapy in patients with head and neck squamous cell carcinoma improves regional control and survivalSven van den Bosch, Patricia A H Doornaert, Tim Dijkema, et al.
Malaria Journal|August 26, 2011
A cluster-randomized trial of mass drug administration with a gametocytocidal drug combination to interrupt malaria transmission in a low endemic area in TanzaniaSeif A Shekalaghe, Chris Drakeley, Sven van den Bosch, et al.
Antimicrobial Agents and Chemotherapy|March 3, 2010
In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individualsSeif A Shekalaghe, Roel ter Braak, Modibo Daou, et al.
BMC Cancer|March 23, 2017
Uniform FDG-PET guided GRAdient Dose prEscription to reduce late Radiation Toxicity (UPGRADE-RT): study protocol for a randomized clinical trial with dose reduction to the elective neck in head and neck squamous cell carcinomaSven van den Bosch, Tim Dijkema, Martina C Kunze-Busch, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Seminars in Radiation Oncology|June 18, 2023
[18F]FDG-PET-Based Personalized Radiotherapy Dose PrescriptionJohannes H A M Kaanders, Johan Bussink, Erik H J G Aarntzen, et al.
Head & Neck|March 7, 2017
Reirradiation of head and neck cancer: Long-term disease control and toxicityWouter T C Bots, Sven van den Bosch, Ellen M Zwijnenburg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 15, 2025
Clinical Benefit and Safety of Reduced Elective Dose in Definitive Radiotherapy for Head and Neck Squamous Cell Carcinoma: The UPGRADE-RT Multicenter Randomized Controlled TrialSven van den Bosch, Patricia A H Doornaert, Frank J P Hoebers, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 7, 2025
Dose de-escalation of elective neck irradiation in head and neck cancer: A secondary analysis of acute toxicity findings from the randomized controlled UPGRADE-RT trialSven van den Bosch, Maurice C Cox, Patricia A H Doornaert, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 24, 2019
<sup>18</sup>F-FDG-PET/CT-based treatment planning for definitive (chemo)radiotherapy in patients with head and neck squamous cell carcinoma improves regional control and survivalSven van den Bosch, Patricia A H Doornaert, Tim Dijkema, et al.
Malaria Journal|August 26, 2011
A cluster-randomized trial of mass drug administration with a gametocytocidal drug combination to interrupt malaria transmission in a low endemic area in TanzaniaSeif A Shekalaghe, Chris Drakeley, Sven van den Bosch, et al.
Antimicrobial Agents and Chemotherapy|March 3, 2010
In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individualsSeif A Shekalaghe, Roel ter Braak, Modibo Daou, et al.
BMC Cancer|March 23, 2017
Uniform FDG-PET guided GRAdient Dose prEscription to reduce late Radiation Toxicity (UPGRADE-RT): study protocol for a randomized clinical trial with dose reduction to the elective neck in head and neck squamous cell carcinomaSven van den Bosch, Tim Dijkema, Martina C Kunze-Busch, et al.
Pageof 2